Literature DB >> 32292837

Running a Radiation Oncology Department at the Time of Coronavirus: An Italian Experience.

Marco Krengli1,2, Eleonora Ferrara1, Federico Mastroleo1,2, Marco Brambilla3, Umberto Ricardi4.   

Abstract

Starting from Wuhan, China, SARS-CoV-2 has been a catastrophic epidemic involving many countries worldwide. After China, Italy has been heavily affected, and severe measures to limit the spread of the virus have been taken in the last weeks. Radiation oncology departments must guarantee optimal cancer treatments even in such a challenging scenario of an ongoing aggressive epidemic. Adopted preventive measures and recommendations are highlighted for patients, professionals, and clinical operations to minimize the risk of infection while safely treating patients with cancer.
© 2020 The Authors.

Entities:  

Year:  2020        PMID: 32292837      PMCID: PMC7102610          DOI: 10.1016/j.adro.2020.03.003

Source DB:  PubMed          Journal:  Adv Radiat Oncol        ISSN: 2452-1094


Timeline of Spread of the Virus and Health Ministry Recommendations

From the first days of 2020, SARS-CoV-2 has been the main topic discussed all over the world. Starting from Wuhan, China, its diffusion has been facilitated from the continuous migration of people , both for travel and work purposes. The related disease, COVID-19, was designated a Public Health Emergency of International Concern by the World Health Organization on January 30, 2020, and was considered a pandemic on March 11, 2020. Epidemiologic data published so far in China suggest that onco-hematologic patients are at increased risk of contracting the virus and face severe consequences from SARS-CoV-2 infection, with greater need for intensive care and higher mortality rates, thus calling into question the risk–benefit analysis of potentially immunosuppressive cancer treatments, especially in elderly patients or in the case of adjuvant therapies. The main measure to limit the SARS-CoV-2 diffusion is quarantine: People are forced to stay at home to prevent its spread. China, as the first nation affected, adopted these measures at the end of January. On January 31, 2020, Italy met SARS-CoV-2. A Chinese couple from Wuhan was hospitalized for malaise and high fever in Rome during their trip. The positive tests alarmed the whole country, and a series of precautionary measures were taken: identification of people who were in contact with the couple, cancelation of direct flights to and from China, airlift of Italians in Wuhan back to Italy with a mandatory 14-day quarantine, temperature screening for passengers arriving at any Italian airport, and 14-day self-isolation for people with symptoms or who are at risk. On February 20, 2020, Patient 1 was identified in Codogno, near Milan, Lombardy: he was the first Italian affected by SARS-CoV-2. Lombardy remains the principal cluster of the outbreak. He was involuntarily responsible for the first diffusion of SARS-CoV-2 in Italy, in light of his active social life and his hospitalization for “malaise” erroneously attributed simple influenza. The patient was treated by health professionals with no adequate protective devices. This was the beginning of the spread of infection, resulting in a second cluster in Veneto, and the first “red zone” was created. The “red zone” included 11 towns in these 2 regions. People living here had to stay at home and were not allowed to leave, and no one was allowed to enter the area. Public transportation was blocked, and only shops selling necessities were open. Nearby, a moderate-risk “yellow area” was established with the mandatory closure of schools and universities and some public areas and the strong recommendation to follow some general rules: maintain 1 m safety distance between customers in shops and restaurants; cancel events and ceremonies; and close all shopping centers during the weekends. Starting from the initial shutdown of universities and enforcement of social/work life restrictions, a massive migration of people from the north to the south of Italy potentially contributed to the spread of SARS-CoV-2 in the southern regions. On March 8, 2020, all northern Italy became a “red zone” with the same restrictions applied previously. The next day, the lockdown was extended to all regions of Italy, affecting around 60 million people. Special recommendations for oncologic patients were published on March 10: avoidance of crowded places, wearing of a surgical mask in public spaces, need for careful hand hygiene, and restriction of visits from relatives and friends were all requested.1, 2, 3 The government indication for hospitals concerning patients with cancer was to postpone follow-up visits whenever possible and to establish pathways and spaces dedicated to oncologic patients. The Italian government has created a website to keep track of the SARS-CoV-2 spread and real-time statistics.

Operational Plans

The University Hospital “Maggiore della Carità” of Novara, is in the Piedmont Region in the northwest of Italy and about 40 km from Milan. It is a general hospital hosting about 700 inpatients and is the hub of the northeast of the region, covering an area with 1 million inhabitants. The radiation oncology department is split between 2 nearby hospitals, 20 km apart. We treat an average of 120 patients on 4 linear accelerators and perform about 10 first visits every day. In addition, the medical and nursing staff manages 4 hospital beds for inpatients who require special support for concomitant chemoradiation and management of treatment toxicity.

Patient access for consultation/treatments

Starting on February 24, some access restrictions to our department were established. Patients with respiratory symptoms (fever, cough, conjunctivitis, rhinitis) were not admitted and were invited to contact their general practitioner or the emergency number set up by the Health Ministry. To reduce public access, caregivers were not admitted to the department unless accompanying patients who were non self-sufficient. No limitations were placed on the routine activities of the department of radiation oncology. With the increased spread of the infection and the establishment of the “red zone” on the March 8, new measures were adopted, such as the opening of just one access gate to the university hospital. In this entrance, a first triage was performed by measuring patients’ temperature and evaluating them for symptoms (cough, dyspnea). Those with a temperature of >37.5°C and the presence of symptoms underwent further investigations. At the department entrance, patients were asked to fill in a special medical history form; the form required them to declare respiratory symptoms and contact with people with suspected or confirmed SARS-CoV-2 infection in the last 14 days. In the case of an affirmative answer to one of these items, a surgical mask was provided. Each patient was invited to wash his or her hands with alcohol-based products and use a surgical mask. A specific bracelet with the current date was given to each patient after triage. In the waiting rooms, the chairs were spaced to keep at least 1 m of distance between patients. Magazines and information brochures were removed from waiting rooms to reduce possible sources of contact contagion. The standard hygiene procedures in treatment rooms, computed tomography (CT) simulation, and consultation rooms have been stressed and respected by all the personnel: The surfaces are disinfected with alcoholic solutions after every procedure and disposable sheets, as usual, have been used.

Patient support

Oncologic patients are quite fragile from both physical and psychologic points of view. Moreover, many are elderly and more susceptible to aggressive coronavirus infection. Nurses, technologists, and physicians had to spend much time giving information, explaining prevention measures, and reassuring patients. Thus far, no one has canceled appointments, but some have asked to postpone the first consultation or the simulation procedure. Very few patients under treatment interrupted their treatment course, and some needed help to access the service because of a lack of volunteer transportation. Counseling for psychologic support is offered to both patients and professionals.

Reorganization of activities

Since March 8, all scheduled visits have been critically evaluated by clinicians. We are postponing follow-up visits; nurses contact patients by phone, asking for the results of the last tests performed and proposing a new appointment at the end of the current situation if negative. If there is a suspicion of relapse, a radiation oncologist evaluates the need for further investigation or an appointment. We did not postpone the first consultation of patients who need treatments for malignant tumors. We considered postponement of some treatments, such as those for prostate cancer under hormone therapy and those for adjuvant purposes, especially in elderly patients, but always keeping the timing indicated by the international guidelines. The appointment time for visits and CT simulation are scattered across the day to minimize the number of people in the waiting rooms. Our daily staff meeting has not been suspended, but only the clinicians directly involved in the management of the clinical cases of the day can participate, to reduce the number of people in the meeting room and maintain the 1 m distance. Multidisciplinary meetings are not postponed, but it was decided to reduce the number of clinicians or discuss the clinical cases by videoconference or phone whenever possible. Of note, we decided to postpone a not-urgent brachytherapy treatment because the dedicated room was used for isolating a patient with suspected SARS-CoV-2 infection.

Staff professionals

All staff members wear a surgical mask and gloves when visiting patients. Triage nurses wear surgical masks, gloves, and disposable surgical coats. The use of FFP2 or FFP3 masks is reserved for hospital staff who assist patients with respiratory infections (flu, tuberculosis) or are COVID positive. Staff members are invited to measure body temperature daily and asked not to go to work if it is above 37.5°C or if they have respiratory symptoms. All permissions for personal absences of the medical, technical, nursing, and administrative staff have been suspended.

Medical physics

The medical physics service in the hospital works by prioritizing essential and urgent tasks and postponing those tasks that can tolerate delays (eg, those scheduled annually). Special attention is paid to risk assessment for the use of mobile radiography or CT scanning in new locations of the hospital and for testing and commissioning of additional portable equipment and scanners. Moreover, physicists may be involved in biomedical engineering departments by providing assistance with patient monitoring and organ support equipment (eg, ventilators) or assessing the safety of face masks in magnetic resonance imaging scanner. Quality control in radiation therapy mainly focuses on equipment and dosimetry checks connected with advanced radiation therapy treatments (volumetric modulated arc therapy, stereotactic body radiation therapy, stereotactic radiosurgery, image-guided radiation therapy) and dosimetry assessment associated with radiation therapy treatment planning. To prevent the spread of the virus, they tend to work from home whenever possible, entering clinical locations if necessary but ensuring that staff resources are available for service demands.

Academic teaching activity

Universities, including medical schools, stopped their regular teaching activity in the whole country based on Ministry directive. However, teaching at a distance is performed using online platforms and live-streaming lessons. Some other educational and training activities are still going on in collaboration with the National Health System: Medical students can be admitted to the departments on a voluntary basis but only in the last year of internship and for thesis preparation, and residents are continuing their educational program regularly and are encouraged to participate in the management of SARS-CoV-2–related activities. Several senior residents in emergency medicine, internal medicine, anesthesiology, pneumology, and geriatrics have been recruited by the hospitals in the Piedmont region to assist patients affected by SARS-CoV-2 infection, following the Ministry directive in agreement with academic institutions.

Lessons Learned

This is the first time in recent decades that an epidemic has spread worldwide with such aggressiveness, representing a real emergency for the whole population. The health system, including the main hospitals, is facing the epidemic with few effective weapons. Radiation therapy departments are potentially as exposed as the others to the epidemic, and this represents a crucial issue because most oncology patients have various degrees of immunodeficiency and are elderly, which is an additional risk factor. On the other hand, patients with cancer cannot interrupt treatments, and the whole staff of the radiation therapy department is asked to guarantee efficiency and safety for radiation treatments. Over the last few weeks, all professionals have worked in stressful conditions along a learning curve that is still ongoing. However, a few issues can be already pointed out as lesson learned: Adoption of strict rules from the very beginning in cases of infectious emergency General rules such as 1 m distance, no handshake or other contact, and washing hands frequently Special attention to room and equipment disinfection Adoption of surgical masks for patients and for professionals approaching patients with cancer Maintenance of adequate warehouse stock of masks, sheets, gloves, alcoholic cleaning solutions, and disposable devices (shortage of these materials can become a problem) Providing complete and regular information to patients and professionals Flexibility if other units need support (warehouse, personnel) Importance of sharing experiences among centers

Recommendations

To provide recommendations is not an easy task when the epidemic is ongoing and the effectiveness of some of our preventive measures is still under discussion. However, a few measures aiming at reducing the impact of the epidemic can be highlighted: Establishment of a coordination unit with representatives of all professionals at hospital and department levels Unique source for communication to have clear and timely information and avoid redundancy and conflicting messages General rules for prevention and personal behavior with detailed information to all professionals from the very beginning (procedures for disinfection of rooms and machines, optimizing pathways and waiting rooms strictly for patients, precise timing for consultations to avoid unnecessary waiting time, washing hands frequently, using surgical mask for operators and for patients/accompanying persons) Review of organizational procedures: postponement of treatments for low-priority cases (eg, prostate cancer with hormone therapy, benign diseases), favor short-term treatment (hypofractionation), skip follow-up visits (use phone contact) Definition of a priori policy for patients with suspected or confirmed coronavirus infection at the beginning and during treatment (recommended not to start treatment and recommended to interrupt treatment) Triage procedure at the entrance of the department for all patients and accompanying persons: first access, questionnaire, temperature measurement, check for symptoms; daily treatment, temperature measurement, check for symptoms Check warehouse stock for masks, coats, gloves, alcoholic cleaning solutions, and disposable devices Plan for transportation of patients who cannot be supported by family or volunteers Organization of psychologic support for patients’ families and professionals We need more time to understand the most appropriate behavior for preventing infection while treating our patients. Data collection and large collaboration among centers worldwide are needed to understand the real impact of the SARS-CoV-2 epidemic on the population of patients with cancer undergoing radiation therapy. This epidemic has an impact also on professionals, not only in terms of risk of infection but also in terms of psychologic stress. These aspects should be considered carefully if we would like to maintain a good level of assistance for our patients.
  2 in total

Review 1.  Epidemiology, Diagnosis, Treatment, and Prevention of Influenza Infection in Oncology Patients.

Authors:  Razan El Ramahi; Alison Freifeld
Journal:  J Oncol Pract       Date:  2019-04       Impact factor: 3.840

2.  Cancer patients in SARS-CoV-2 infection: a nationwide analysis in China.

Authors:  Wenhua Liang; Weijie Guan; Ruchong Chen; Wei Wang; Jianfu Li; Ke Xu; Caichen Li; Qing Ai; Weixiang Lu; Hengrui Liang; Shiyue Li; Jianxing He
Journal:  Lancet Oncol       Date:  2020-02-14       Impact factor: 41.316

  2 in total
  28 in total

Review 1.  The Impact of the SARS-CoV-2 Pandemic on Healthcare Provision in Italy to non-COVID Patients: a Systematic Review.

Authors:  Gianmarco Lugli; Matteo Maria Ottaviani; Annarita Botta; Guido Ascione; Alessandro Bruschi; Federico Cagnazzo; Lorenzo Zammarchi; Paola Romagnani; Tommaso Portaluri
Journal:  Mediterr J Hematol Infect Dis       Date:  2022-01-01       Impact factor: 2.576

2.  Follow-Up and Management of Patients With Head and Neck Cancer During the 2019 Novel Coronavirus (SARS-CoV-2) Disease Pandemic.

Authors:  Melvin L K Chua; Daniel J Ma; Carryn M Anderson; Sana D Karam; Danielle N Margalit; Randall J Kimple
Journal:  Adv Radiat Oncol       Date:  2020-05-15

Review 3.  Radiation therapy considerations during the COVID-19 Pandemic: Literature review and expert opinions.

Authors:  Pranshu Mohindra; Courtney R Buckey; Shifeng Chen; Terence T Sio; Yi Rong
Journal:  J Appl Clin Med Phys       Date:  2020-05-14       Impact factor: 2.102

4.  Practical indications for management of patients candidate to Interventional and Intraoperative Radiotherapy (Brachytherapy, IORT) during COVID-19 pandemic - A document endorsed by AIRO (Italian Association of Radiotherapy and Clinical Oncology) Interventional Radiotherapy Working Group.

Authors:  Andrea Vavassori; Luca Tagliaferri; Lisa Vicenzi; Andrea D'Aviero; Antonella Ciabattoni; Sergio Gribaudo; Loredana Lapadula; Gian Carlo Mattiucci; Lorenzo Vinante; Vitaliana De Sanctis; Cristiana Vidali; Rita Murri; Maria Antonietta Gambacorta; Marcello Mignogna; Barbara A Jereczek-Fossa; Vittorio Donato
Journal:  Radiother Oncol       Date:  2020-05-08       Impact factor: 6.280

5.  Influence of the pandemic dissemination of COVID-19 on radiotherapy practice: A flash survey in Germany, Austria and Switzerland.

Authors:  Melanie Reuter-Oppermann; Ralf Müller-Polyzou; Holger Wirtz; Anthimos Georgiadis
Journal:  PLoS One       Date:  2020-05-21       Impact factor: 3.240

6.  A Call for a Radiation Oncology Model Based on New 4R's During the COVID-19 Pandemic.

Authors:  Shrinivas Rathod; Arbind Dubey; Amitava Chowdhury; Bashir Bashir; Rashmi Koul
Journal:  Adv Radiat Oncol       Date:  2020-04-25

7.  COVID-19 outbreak and cancer radiotherapy disruption in Italy: Survey endorsed by the Italian Association of Radiotherapy and Clinical Oncology (AIRO).

Authors:  Barbara Alicja Jereczek-Fossa; Matteo Pepa; Giulia Marvaso; Alessio Bruni; Michela Buglione di Monale E Bastia; Gianpiero Catalano; Andrea Riccardo Filippi; Pierfrancesco Franco; Maria Antonietta Gambacorta; Domenico Genovesi; Giuseppe Iatì; Alessandro Magli; Luigi Marafioti; Icro Meattini; Anna Merlotti; Marcello Mignogna; Daniela Musio; Roberto Pacelli; Stefano Pergolizzi; Vincenzo Tombolini; Marco Trovò; Umberto Ricardi; Stefano Maria Magrini; Renzo Corvò; Vittorio Donato
Journal:  Radiother Oncol       Date:  2020-05-12       Impact factor: 6.280

8.  The 3 Bs of cancer care amid the COVID-19 pandemic crisis: "Be safe, be smart, be kind"-A multidisciplinary approach increasing the use of radiation and embracing telemedicine for head and neck cancer.

Authors:  Jung Julie Kang; Richard J Wong; Eric J Sherman; Alisa Rybkin; Sean M McBride; Nadeem Riaz; C Jillian Tsai; Yao Yu; Linda Chen; Kaveh Zakeri; Daphna Y Gelblum; Erin F Gillespie; Marc A Cohen; Jennifer R Cracchiolo; Ian Ganly; Snehal Patel; Bhuvanesh Singh; Jay O Boyle; Benjamin R Roman; Luc G Morris; Ashok R Shaha; Lara A Dunn; Alan L Ho; James V Fetten; Jatin P Shah; David G Pfister; Nancy Y Lee
Journal:  Cancer       Date:  2020-07-08       Impact factor: 6.921

9.  Post-lockdown management of oncological priorities and postponed radiation therapy following the COVID-19 pandemic: Experience of the Institut Curie.

Authors:  Arnaud Beddok; Valentin Calugaru; Mathieu Minsat; Rémi Dendale; Aurélien De Oliveira; Émilie Costa; Farid Goudjil; Rezart Belshi; Noelle Pierrat; Christophe Rochas; Anne Catherine Gravigny; Lucas Soisick; Hélène Colella Fleury; Gilles Créhange
Journal:  Radiother Oncol       Date:  2020-06-05       Impact factor: 6.280

10.  The COVID-19 pandemic: A rapid global response for children with cancer from SIOP, COG, SIOP-E, SIOP-PODC, IPSO, PROS, CCI, and St Jude Global.

Authors:  Michael Sullivan; Eric Bouffet; Carlos Rodriguez-Galindo; Sandra Luna-Fineman; Muhammad Saghir Khan; Pam Kearns; Douglas S Hawkins; Julia Challinor; Lisa Morrissey; Jörg Fuchs; Karen Marcus; Adriana Balduzzi; Luisa Basset-Salom; Miguela Caniza; Justin N Baker; Rejin Kebudi; Laila Hessissen; Richard Sullivan; Kathy Pritchard-Jones
Journal:  Pediatr Blood Cancer       Date:  2020-05-13       Impact factor: 3.838

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.